Relmada Therapeutics, Inc. (RLMD) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Relmada Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -3.32x | -0.20x | -0.31x | -0.16x | -0.63x | -1.68x |
| P/B Ratio | 2.20x | 0.44x | 0.36x | 0.18x | 0.38x | 0.95x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 14.62x | 4.45x | 8.00x | 12.26x | 14.83x | 9.37x |
| Quick Ratio | 14.62x | 4.45x | 8.00x | 12.26x | 14.83x | 9.37x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..